Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | AVPR2 | P30518 | 9/20 | 0.42 |
| ▸ | AVPR1A | P37288 | 3/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | VNN1 | O95497 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3552426 | 0.92 | HTT (0.47) | HTTKMT2AAVPR2AVPR1APPARG | |
| SCHEMBL3552714 | 0.92 | HTT (0.49) | HTTKMT2AAVPR2AVPR1APPARG | |
| SCHEMBL3552037 | 0.91 | HTT (0.50) | HTTKMT2AAVPR2AVPR1APPARG | |
| SCHEMBL3550260 | 0.91 | KMT2A (0.46) | HTTKMT2AAVPR2AVPR1APPARG | |
| SCHEMBL3553244 | 0.90 | HTT (0.45) | HTTKMT2AAVPR2AVPR1APPARG | |
| SCHEMBL3553030 | 0.90 | HTT (0.49) | HTTKMT2AAVPR2AVPR1APPARG | |
| SCHEMBL3555235 | 0.90 | AVPR1A (0.42) | HTTKMT2AAVPR2AVPR1ALMNA | |
| SCHEMBL3550605 | 0.90 | AVPR1A (0.43) | HTTKMT2AAVPR2AVPR1ALMNA | |
| SCHEMBL3550434 | 0.89 | AVPR1A (0.42) | HTTKMT2AAVPR2AVPR1ALMNA | |
| SCHEMBL3556720 | 0.89 | AVPR1A (0.51) | HTTKMT2AAVPR2AVPR1APPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7678787-B2 | Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists | WYETH (US) | 2010-03-16 | — | — | US | claimed |
| US-20060287522-A1 | Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists | WYETH (US) | 2006-12-21 | — | — | US | claimed |
| US-7678787-B2 | Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists | WYETH (US) | 2010-03-16 | — | — | US | disclosed |
| US-20060287522-A1 | Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists | WYETH (US) | 2006-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287522-A1 | Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists | FSHR, GNRHR, PRLHR | HTT 2736/4885KMT2A 1322/4885AVPR2 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.